Global Theraputic Drug Monitorings Market Status and Outlook 2023-2028

Report Format: PDF   |   Report ID: 5657902   |   Published Date: January 2023   |   Pages:  120  

Choose License
Therapeutic drug monitoring (TDM) is a branch of clinical chemistry and clinical pharmacology that specializes in the measurement of medication levels in blood. Its main focus is on drugs with a narrow therapeutic range, i.e. drugs that can easily be under- or overdosed.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period.
Data collected includes market dynamics, technology outlook, application development, and pricing trends. All of this is fed into a research model, which then produces relevant data for market research. Global market trend analysis is given including historical data, estimates to 20233 and compound annual growth rate (CAGR) forecast to 2028.
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
2023 will be a tough year for much of the global economy, as the ongoing war in Ukraine continues to strain trade, especially in Europe, and the global economy remains reeling from the fallout from the COVID-19 pandemic.
But as China moves ever closer to fully reemerging from three years of government-imposed Covid isolation and reintegrating with the world, economic expectations are high.And with the global economy now facing significant challenges, including energy shortages, slowing growth and high inflation, China's reopening could provide a much-needed and timely boost.
Studying and analyzing the impact of Coronavirus COVID-19 on the Theraputic Drug Monitorings industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
    Chemiluminescence Immunoassay (CLIA)
    Fluorescence Immunoassay (FPIA)
    Radioimmunoassay (RIA)
    Colorimetric Immunoassay
    Other Immunoassays
Market Segment by Product Application
    Antiepileptic Drugs
    Immunosuppressant
    Antitumor Drugs
    Psychotropic Drugs
    Antibiotic
    Antifungal
    Cardiovascular Drugs
    Antiasthmatic
    Others
Finally, the report provides detailed profile and data information analysis of leading company.
    Roche AG
    DiaSorin
    Beckman Coulter
    Siemens Healthineers
    Sekisui Medical
    Thermo Fisher Scientific
    Grifols
    BioM?(C)rieux
    Agilent Technologies
    Fujirebio
    Chromsystems
    ALPCO
    Ortho-Clinical Diagnostics
    MedTox
    Bio-Rad
    Tosoh
    Quest Diagnostics
    BIOHIT Healthcare
    R-Biopharm AG
    Sysmex
    Wieslab
    Omnica
    ARK Diagnostics
    Probe Scientific
Insights and Tools:
We follow a comprehensive process to estimate market size. Key industry dynamics, regulatory scenarios, and segmental dynamics are analyzed to understand their impact on demand over the forecast period. Macroeconomic indicators such as prices, income and demographic changes, demand changes, etc. are considered in estimating market size. We also provide an in-depth profile of the key players and discuss their market shares in the global market to derive the market value. In addition, we have an internal database that is regularly updated with key insights and press releases from key stakeholders in the relevant market.
The data is generally gathered in various arrangements such as charts, graphs, infographics, trends, documents and records from various manufacturers and retailers. Our analyst gather, collect, and interpret such data to form significant databases. Our team then works with large data volumes to analyze core developments, evaluate market estimations, and identify trends.
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
Research Objectives
    1.To study and analyze the global Theraputic Drug Monitorings consumption (value) by key regions/countries, product type and application, history data from 2018 to 2022, and forecast to 2028.
    2.To understand the structure of Theraputic Drug Monitorings market by identifying its various subsegments.
    3.Focuses on the key global Theraputic Drug Monitorings manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
    4.To analyze the Theraputic Drug Monitorings with respect to individual growth trends, future prospects, and their contribution to the total market.
    5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    6.To project the consumption of Theraputic Drug Monitorings submarkets, with respect to key regions (along with their respective key countries).
    7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents

Global Theraputic Drug Monitorings Market Status and Outlook 2023-2028

Market Study Overview
    1.1 Study Objectives
    1.2 Theraputic Drug Monitorings Introduce
    1.3 Combined with the Analysis of Macroeconomic Indicators
    1.4 Brief Description of Research methods
    1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
    2.1 Theraputic Drug Monitorings Segment by Type
        2.1.1 Chemiluminescence Immunoassay (CLIA)
        2.1.2 Fluorescence Immunoassay (FPIA)
        2.1.3 Radioimmunoassay (RIA)
        2.1.4 Colorimetric Immunoassay
        2.1.5 Other Immunoassays
    2.2 Market Analysis by Application
        2.2.1 Antiepileptic Drugs
        2.2.2 Immunosuppressant
        2.2.3 Antitumor Drugs
        2.2.4 Psychotropic Drugs
        2.2.5 Antibiotic
        2.2.6 Antifungal
        2.2.7 Cardiovascular Drugs
        2.2.8 Antiasthmatic
        2.2.9 Others
    2.3 Global Theraputic Drug Monitorings Market Comparison by Regions (2018-2028)
        2.3.1 Global Theraputic Drug Monitorings Market Size (2018-2028)
        2.3.2 North America Theraputic Drug Monitorings Status and Prospect (2018-2028)
        2.3.3 Europe Theraputic Drug Monitorings Status and Prospect (2018-2028)
        2.3.4 Asia-pacific Theraputic Drug Monitorings Status and Prospect (2018-2028)
        2.3.5 South America Theraputic Drug Monitorings Status and Prospect (2018-2028)
        2.3.6 Middle East & Africa Theraputic Drug Monitorings Status and Prospect (2018-2028)
    2.5 Coronavirus Disease 2020 (Covid-19): Theraputic Drug Monitorings Industry Impact
        2.5.1 Theraputic Drug Monitorings Business Impact Assessment - Covid-19
        2.5.2 Market Trends and Theraputic Drug Monitorings Potential Opportunities in the COVID-19 Landscape
        2.5.3 Measures / Proposal against Covid-19

3 Competition by Vendors
    3.1 Global Theraputic Drug Monitorings Revenue and Market Share by Vendors (2018-2023)
    3.2 Global Theraputic Drug Monitorings Industry Concentration Ratio (CR5 and HHI)
    3.3 Top 5 Theraputic Drug Monitorings Vendors Market Share
    3.4 Top 10 Theraputic Drug Monitorings Vendors Market Share
    3.5 Date of Key Vendors Enter into Theraputic Drug Monitorings Market
    3.6 Key Vendors Theraputic Drug Monitorings Product Offered
    3.7 Mergers & Acquisitions Planning

4 Analysis of Theraputic Drug Monitorings Industry Key Vendors
    4.1 Roche AG
        4.1.1 Company Details
        4.1.2 Product Introduction, Application and Specification
        4.1.3 Roche AG Theraputic Drug Monitorings Gross Margin, and Revenue (2018-2023)
        4.1.4 Main Business Overview
        4.1.5 Roche AG News
    4.2 DiaSorin
        4.2.1 Company Details
        4.2.2 Product Introduction, Application and Specification
        4.2.3 DiaSorin Theraputic Drug Monitorings Gross Margin, and Revenue (2018-2023)
        4.2.4 Main Business Overview
        4.2.5 DiaSorin News
    4.3 Beckman Coulter
        4.3.1 Company Details
        4.3.2 Product Introduction, Application and Specification
        4.3.3 Beckman Coulter Theraputic Drug Monitorings Gross Margin, and Revenue (2018-2023)
        4.3.4 Main Business Overview
        4.3.5 Beckman Coulter News
    4.4 Siemens Healthineers
        4.4.1 Company Details
        4.4.2 Product Introduction, Application and Specification
        4.4.3 Siemens Healthineers Theraputic Drug Monitorings Gross Margin, and Revenue (2018-2023)
        4.4.4 Main Business Overview
        4.4.5 Siemens Healthineers News
    4.5 Sekisui Medical
        4.5.1 Company Details
        4.5.2 Product Introduction, Application and Specification
        4.5.3 Sekisui Medical Theraputic Drug Monitorings Gross Margin, and Revenue (2018-2023)
        4.5.4 Main Business Overview
        4.5.5 Sekisui Medical News
    4.6 Thermo Fisher Scientific
        4.6.1 Company Details
        4.6.2 Product Introduction, Application and Specification
        4.6.3 Thermo Fisher Scientific Theraputic Drug Monitorings Gross Margin, and Revenue (2018-2023)
        4.6.4 Main Business Overview
        4.6.5 Thermo Fisher Scientific News
    4.7 Grifols
        4.7.1 Company Details
        4.7.2 Product Introduction, Application and Specification
        4.7.3 Grifols Theraputic Drug Monitorings Gross Margin, and Revenue (2018-2023)
        4.7.4 Main Business Overview
        4.7.5 Grifols News
    4.8 BioM?(C)rieux
        4.8.1 Company Details
        4.8.2 Product Introduction, Application and Specification
        4.8.3 BioM?(C)rieux Theraputic Drug Monitorings Gross Margin, and Revenue (2018-2023)
        4.8.4 Main Business Overview
        4.8.5 BioM?(C)rieux News
    4.9 Agilent Technologies
        4.9.1 Company Details
        4.9.2 Product Introduction, Application and Specification
        4.9.3 Agilent Technologies Theraputic Drug Monitorings Gross Margin, and Revenue (2018-2023)
        4.9.4 Main Business Overview
        4.9.5 Agilent Technologies News
    4.10 Fujirebio
        4.10.1 Company Details
        4.10.2 Product Introduction, Application and Specification
        4.10.3 Fujirebio Theraputic Drug Monitorings Gross Margin, and Revenue (2018-2023)
        4.10.4 Main Business Overview
        4.10.5 Fujirebio News
    4.11 Chromsystems
        4.11.1 Company Details
        4.11.2 Product Introduction, Application and Specification
        4.11.3 Chromsystems Theraputic Drug Monitorings Gross Margin, and Revenue (2018-2023)
        4.11.4 Main Business Overview
        4.11.5 Chromsystems News
    4.12 ALPCO
        4.12.1 Company Details
        4.12.2 Product Introduction, Application and Specification
        4.12.3 ALPCO Theraputic Drug Monitorings Gross Margin, and Revenue (2018-2023)
        4.12.4 Main Business Overview
        4.12.5 ALPCO News
    4.13 Ortho-Clinical Diagnostics
        4.13.1 Company Details
        4.13.2 Product Introduction, Application and Specification
        4.13.3 Ortho-Clinical Diagnostics Theraputic Drug Monitorings Gross Margin, and Revenue (2018-2023)
        4.13.4 Main Business Overview
        4.13.5 Ortho-Clinical Diagnostics News
    4.14 MedTox
        4.14.1 Company Details
        4.14.2 Product Introduction, Application and Specification
        4.14.3 MedTox Theraputic Drug Monitorings Gross Margin, and Revenue (2018-2023)
        4.14.4 Main Business Overview
        4.14.5 MedTox News
    4.15 Bio-Rad
        4.15.1 Company Details
        4.15.2 Product Introduction, Application and Specification
        4.15.3 Bio-Rad Theraputic Drug Monitorings Gross Margin, and Revenue (2018-2023)
        4.15.4 Main Business Overview
        4.15.5 Bio-Rad News
    4.16 Tosoh
        4.16.1 Company Details
        4.16.2 Product Introduction, Application and Specification
        4.16.3 Tosoh Theraputic Drug Monitorings Gross Margin, and Revenue (2018-2023)
        4.16.4 Main Business Overview
        4.16.5 Tosoh News
    4.17 Quest Diagnostics
        4.17.1 Company Details
        4.17.2 Product Introduction, Application and Specification
        4.17.3 Quest Diagnostics Theraputic Drug Monitorings Gross Margin, and Revenue (2018-2023)
        4.17.4 Main Business Overview
        4.17.5 Quest Diagnostics News
    4.18 BIOHIT Healthcare
        4.18.1 Company Details
        4.18.2 Product Introduction, Application and Specification
        4.18.3 BIOHIT Healthcare Theraputic Drug Monitorings Gross Margin, and Revenue (2018-2023)
        4.18.4 Main Business Overview
        4.18.5 BIOHIT Healthcare News
    4.19 R-Biopharm AG
        4.19.1 Company Details
        4.19.2 Product Introduction, Application and Specification
        4.19.3 R-Biopharm AG Theraputic Drug Monitorings Gross Margin, and Revenue (2018-2023)
        4.19.4 Main Business Overview
        4.19.5 R-Biopharm AG News
    4.20 Sysmex
        4.20.1 Company Details
        4.20.2 Product Introduction, Application and Specification
        4.20.3 Sysmex Theraputic Drug Monitorings Gross Margin, and Revenue (2018-2023)
        4.20.4 Main Business Overview
        4.20.5 Sysmex News
    4.21 Wieslab
        4.21.1 Company Details
        4.21.2 Product Introduction, Application and Specification
        4.21.3 Wieslab Theraputic Drug Monitorings Gross Margin, and Revenue (2018-2023)
        4.21.4 Main Business Overview
        4.21.5 Wieslab News
    4.22 Omnica
        4.22.1 Company Details
        4.22.2 Product Introduction, Application and Specification
        4.22.3 Omnica Theraputic Drug Monitorings Gross Margin, and Revenue (2018-2023)
        4.22.4 Main Business Overview
        4.22.5 Omnica News
    4.23 ARK Diagnostics
        4.23.1 Company Details
        4.23.2 Product Introduction, Application and Specification
        4.23.3 ARK Diagnostics Theraputic Drug Monitorings Gross Margin, and Revenue (2018-2023)
        4.23.4 Main Business Overview
        4.23.5 ARK Diagnostics News
    4.24 Probe Scientific
        4.24.1 Company Details
        4.24.2 Product Introduction, Application and Specification
        4.24.3 Probe Scientific Theraputic Drug Monitorings Gross Margin, and Revenue (2018-2023)
        4.24.4 Main Business Overview
        4.24.5 Probe Scientific News

5 Global Theraputic Drug Monitorings Market Size Categorized by Regions
    5.1 Global Theraputic Drug Monitorings Revenue and Market Share by Regions
    5.2 North America Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023)
    5.3 Europe Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023)
    5.4 Asia-pacific Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023)
    5.5 South America Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023)
    5.6 Middle East & Africa Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023)

6 North America Theraputic Drug Monitorings Market Size Categorized by Countries
    6.1 North America Theraputic Drug Monitorings Revenue and Market Share by Countries
        6.1.1 North America Theraputic Drug Monitorings Market Size by Countries (2018-2023)
        6.1.2 United States Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023)
        6.1.3 Canada Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023)
        6.1.4 Mexico Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023)
    6.2 North America Theraputic Drug Monitorings Revenue (Value) by Vendors
    6.3 North America Theraputic Drug Monitorings Revenue and Market Share by Type (2018-2023)
    6.4 North America Theraputic Drug Monitorings Revenue and Market Share by Application (2018-2023)

7 Europe Theraputic Drug Monitorings Market Size Categorized by Countries
    7.1 Europe Theraputic Drug Monitorings Revenue and Market Share by Countries
        7.1.1 Europe Theraputic Drug Monitorings Market Size by Countries (2018-2023)
        7.1.2  Germany Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023)
        7.1.3  UK Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023)
        7.1.4  France Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023)
        7.1.5  Russia Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023)
        7.1.6  Italy Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023)
        7.1.7  Spain Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023)
    7.2  Europe Theraputic Drug Monitorings Revenue (Value) by Vendors
    7.3  Europe Theraputic Drug Monitorings Revenue and Market Share by Type (2018-2023)
    7.4  Europe Theraputic Drug Monitorings Revenue and Market Share by Application (2018-2023)

8 Asia-pacific Theraputic Drug Monitorings Market Size Categorized by Countries
    8.1  Asia-pacific Theraputic Drug Monitorings Revenue and Market Share by Countries
        8.1.1  Asia-pacific Theraputic Drug Monitorings Market Size by Countries (2018-2023)
        8.1.2  China Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023)
        8.1.3  South Korea Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023)
        8.1.4  Japan Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023)
        8.1.5  Australia Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023)
        8.1.6  India Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023)
        8.1.7  Southeast Asia Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023)
    8.2  Asia-pacific Theraputic Drug Monitorings Revenue (Value) by Vendors
    8.3  Asia-pacific Theraputic Drug Monitorings Revenue and Market Share by Type (2018-2023)
    8.4  Asia-pacific Theraputic Drug Monitorings Revenue and Market Share by Application (2018-2023)

9 South America Theraputic Drug Monitorings Market Size Categorized by Countries
    9.1  South America Theraputic Drug Monitorings Revenue and Market Share by Countries
        9.1.1  South America Theraputic Drug Monitorings Market Size by Countries (2018-2023)
        9.1.2  Brazil Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023)
        9.1.3  Chile Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023)
    9.2 South America Theraputic Drug Monitorings Revenue and Market Share by Type (2018-2023)
    9.3  South America Theraputic Drug Monitorings Revenue and Market Share by Application (2018-2023)

10 Middle East and Africa Theraputic Drug Monitorings Market Size Categorized by Countries
    10.1  Middle East and Africa Theraputic Drug Monitorings Revenue and Market Share by Countries
        10.1.1  Middle East and Africa Theraputic Drug Monitorings Market Size by Countries (2018-2023)
        10.1.2  GCC Countries Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023)
        10.1.3  Turkey Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023)
        10.1.4  Egypt Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023)
        10.1.5  South Africa Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023)
    10.2  Middle East and Africa Theraputic Drug Monitorings Revenue and Market Share by Type
    10.3  Middle East and Africa Theraputic Drug Monitorings Revenue Market Share by Application (2018-2023)

11 Global Theraputic Drug Monitorings Market Segment by Type
    11.1 Global Theraputic Drug Monitorings Revenue and Market Share by Type (2018-2023)
    11.2 Chemiluminescence Immunoassay (CLIA) Revenue Growth Rate and Price
    11.3 Fluorescence Immunoassay (FPIA) Revenue Growth Rate and Price
    11.4 Radioimmunoassay (RIA) Revenue Growth Rate and Price
    11.5 Colorimetric Immunoassay Revenue Growth Rate and Price
    11.6 Other Immunoassays Revenue Growth Rate and Price

12 Global Theraputic Drug Monitorings Market Segment by Application
    12.1 Global Theraputic Drug Monitorings Revenue Market Share by Application (2018-2023)
    12.2 Antiepileptic Drugs Revenue Growth Rate (2018-2023)
    12.3 Immunosuppressant Revenue Growth Rate (2018-2023)
    12.4 Antitumor Drugs Revenue Growth Rate (2018-2023)
    12.5 Psychotropic Drugs Revenue Growth Rate (2018-2023)
    12.6 Antibiotic Revenue Growth Rate (2018-2023)
    12.7 Antifungal Revenue Growth Rate (2018-2023)
    12.8 Cardiovascular Drugs Revenue Growth Rate (2018-2023)
    12.9 Antiasthmatic Revenue Growth Rate (2018-2023)
    12.10 Others Revenue Growth Rate (2018-2023)

13 Global Theraputic Drug Monitorings Market Forecast
    13.1 Global Theraputic Drug Monitorings Revenue and Growth Rate (2023-2028)
    13.2 Theraputic Drug Monitorings Market Forecast by Regions (2023-2028)
        13.2.1  North America Theraputic Drug Monitorings Market Forecast (2023-2028)
        13.2.2  Europe Theraputic Drug Monitorings Market Forecast (2023-2028)
        13.2.3  Asia-Pacific Theraputic Drug Monitorings Market Forecast (2023-2028)
        13.2.4  South America Theraputic Drug Monitorings Market Forecast (2023-2028)
        13.2.5  Middle East & Africa Theraputic Drug Monitorings Market Forecast (2023-2028)
    13.3 Theraputic Drug Monitorings Market Forecast by Type (2023-2028)
        13.3.1  Global Theraputic Drug Monitorings Revenue Forecast by Type (2023-2028)
        13.3.2  Global Theraputic Drug Monitorings Market Share Forecast by Type (2023-2028)
    13.4 Theraputic Drug Monitorings Market Forecast by Application (2023-2028)
        13.4.1  Global Theraputic Drug Monitorings Revenue Forecast by Application (2023-2028)

14 Market Analysis
        14.1.1  Market overview
        14.1.2  Market Opportunities
        14.1.3  Market Risk
        14.1.4  Market Driving Force
        14.1.5  Porter's Five Forces Analysis
        14.1.6  SWOT Analysis

15 Downstream Market Analysis
    15.1  Macro Analysis of Down Markets
    15.2  Key Players in Down Markets

16 Research Findings and Conclusion

List of Tables and Figures Figure Product Picture Theraputic Drug Monitorings Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Figure Part of Our External Database Figure Key Executives Interviewed Table Global Theraputic Drug Monitorings Market Size (Million US$) by Type Figure Global Market Share of Theraputic Drug Monitorings by Type in 2022 Figure Chemiluminescence Immunoassay (CLIA) Picture Figure Fluorescence Immunoassay (FPIA) Picture Figure Radioimmunoassay (RIA) Picture Figure Colorimetric Immunoassay Picture Figure Other Immunoassays Picture Table Global Theraputic Drug Monitorings Market Size (Million US$) by Application Figure Global Theraputic Drug Monitorings Market Share by Application in 2022 Figure Antiepileptic Drugs Picture Figure Immunosuppressant Picture Figure Antitumor Drugs Picture Figure Psychotropic Drugs Picture Figure Antibiotic Picture Figure Antifungal Picture Figure Cardiovascular Drugs Picture Figure Antiasthmatic Picture Figure Others Picture Table Global Theraputic Drug Monitorings Comparison by Regions (M USD) 2018-2028 Figure Global Theraputic Drug Monitorings Market Size (Million US$) (2018-2028) Figure North America Theraputic Drug Monitorings Revenue (Million US$) Growth Rate (2018-2028) Figure Europe Theraputic Drug Monitorings Revenue (Million US$) Growth Rate (2018-2028) Figure Asia-pacific Theraputic Drug Monitorings Revenue (Million US$) Growth Rate (2018-2028) Figure South America Theraputic Drug Monitorings Revenue (Million US$) Growth Rate (2018-2028) Figure Middle East & Africa Theraputic Drug Monitorings Revenue (Million US$) Growth Rate (2018-2028) Table Business Impact Assessment - Covid-19 Table Market Trends and Theraputic Drug Monitorings Potential Opportunities in the COVID-19 Landscape Table Measures / Proposal against Covid-19 Table Global Theraputic Drug Monitorings Revenue by Vendors (2018-2023) Figure Global Theraputic Drug Monitorings Revenue Market Share by Vendors in 2022 Table Global Theraputic Drug Monitorings Vendors Market Concentration Ratio (CR5 and HHI) Figure Top 5 Theraputic Drug Monitorings Vendors (Revenue) Market Share in 2022 Figure Top 10 Theraputic Drug Monitorings Vendors (Revenue) Market Share in 2022 Table Date of Key Vendors Enter into Theraputic Drug Monitorings Market Table Key Vendors Theraputic Drug Monitorings Product Type Table Roche AG Company Profile Table Theraputic Drug Monitorings Product Introduction, Application and Specification of Roche AG Table Theraputic Drug Monitorings Revenue (M USD) and Gross Margin of Roche AG 2018-2023 Table Roche AG Main Business Table Roche AG Recent Development Table DiaSorin Company Profile Table Theraputic Drug Monitorings Product Introduction, Application and Specification of DiaSorin Table Theraputic Drug Monitorings Revenue (M USD) and Gross Margin of DiaSorin 2018-2023 Table DiaSorin Main Business Table DiaSorin Recent Development Table DiaSorin Company Profile Table Theraputic Drug Monitorings Product Introduction, Application and Specification of DiaSorin Table Theraputic Drug Monitorings Revenue (M USD) and Gross Margin of DiaSorin 2018-2023 Table DiaSorin Main Business Table DiaSorin Recent Development Table Beckman Coulter Company Profile Table Theraputic Drug Monitorings Product Introduction, Application and Specification of Beckman Coulter Table Theraputic Drug Monitorings Revenue (M USD) and Gross Margin of Beckman Coulter 2018-2023 Table Beckman Coulter Main Business Table Beckman Coulter Recent Development Table Siemens Healthineers Company Profile Table Theraputic Drug Monitorings Product Introduction, Application and Specification of Siemens Healthineers Table Theraputic Drug Monitorings Revenue (M USD) and Gross Margin of Siemens Healthineers 2018-2023 Table Siemens Healthineers Main Business Table Siemens Healthineers Recent Development Table Sekisui Medical Company Profile Table Theraputic Drug Monitorings Product Introduction, Application and Specification of Sekisui Medical Table Theraputic Drug Monitorings Revenue (M USD) and Gross Margin of Sekisui Medical 2018-2023 Table Sekisui Medical Main Business Table Sekisui Medical Recent Development Table Thermo Fisher Scientific Company Profile Table Theraputic Drug Monitorings Product Introduction, Application and Specification of Thermo Fisher Scientific Table Theraputic Drug Monitorings Revenue (M USD) and Gross Margin of Thermo Fisher Scientific 2018-2023 Table Thermo Fisher Scientific Main Business Table Thermo Fisher Scientific Recent Development Table Grifols Company Profile Table Theraputic Drug Monitorings Product Introduction, Application and Specification of Grifols Table Theraputic Drug Monitorings Revenue (M USD) and Gross Margin of Grifols 2018-2023 Table Grifols Main Business Table Grifols Recent Development Table BioM?(C)rieux Company Profile Table Theraputic Drug Monitorings Product Introduction, Application and Specification of BioM?(C)rieux Table Theraputic Drug Monitorings Revenue (M USD) and Gross Margin of BioM?(C)rieux 2018-2023 Table BioM?(C)rieux Main Business Table BioM?(C)rieux Recent Development Table Agilent Technologies Company Profile Table Theraputic Drug Monitorings Product Introduction, Application and Specification of Agilent Technologies Table Theraputic Drug Monitorings Revenue (M USD) and Gross Margin of Agilent Technologies 2018-2023 Table Agilent Technologies Main Business Table Agilent Technologies Recent Development Table Fujirebio Company Profile Table Theraputic Drug Monitorings Product Introduction, Application and Specification of Fujirebio Table Theraputic Drug Monitorings Revenue (M USD) and Gross Margin of Fujirebio 2018-2023 Table Fujirebio Main Business Table Fujirebio Recent Development Table Chromsystems Company Profile Table Theraputic Drug Monitorings Product Introduction, Application and Specification of Chromsystems Table Theraputic Drug Monitorings Revenue (M USD) and Gross Margin of Chromsystems 2018-2023 Table Chromsystems Main Business Table Chromsystems Recent Development Table ALPCO Company Profile Table Theraputic Drug Monitorings Product Introduction, Application and Specification of ALPCO Table Theraputic Drug Monitorings Revenue (M USD) and Gross Margin of ALPCO 2018-2023 Table ALPCO Main Business Table ALPCO Recent Development Table Ortho-Clinical Diagnostics Company Profile Table Theraputic Drug Monitorings Product Introduction, Application and Specification of Ortho-Clinical Diagnostics Table Theraputic Drug Monitorings Revenue (M USD) and Gross Margin of Ortho-Clinical Diagnostics 2018-2023 Table Ortho-Clinical Diagnostics Main Business Table Ortho-Clinical Diagnostics Recent Development Table MedTox Company Profile Table Theraputic Drug Monitorings Product Introduction, Application and Specification of MedTox Table Theraputic Drug Monitorings Revenue (M USD) and Gross Margin of MedTox 2018-2023 Table MedTox Main Business Table MedTox Recent Development Table Bio-Rad Company Profile Table Theraputic Drug Monitorings Product Introduction, Application and Specification of Bio-Rad Table Theraputic Drug Monitorings Revenue (M USD) and Gross Margin of Bio-Rad 2018-2023 Table Bio-Rad Main Business Table Bio-Rad Recent Development Table Tosoh Company Profile Table Theraputic Drug Monitorings Product Introduction, Application and Specification of Tosoh Table Theraputic Drug Monitorings Revenue (M USD) and Gross Margin of Tosoh 2018-2023 Table Tosoh Main Business Table Tosoh Recent Development Table Quest Diagnostics Company Profile Table Theraputic Drug Monitorings Product Introduction, Application and Specification of Quest Diagnostics Table Theraputic Drug Monitorings Revenue (M USD) and Gross Margin of Quest Diagnostics 2018-2023 Table Quest Diagnostics Main Business Table Quest Diagnostics Recent Development Table BIOHIT Healthcare Company Profile Table Theraputic Drug Monitorings Product Introduction, Application and Specification of BIOHIT Healthcare Table Theraputic Drug Monitorings Revenue (M USD) and Gross Margin of BIOHIT Healthcare 2018-2023 Table BIOHIT Healthcare Main Business Table BIOHIT Healthcare Recent Development Table R-Biopharm AG Company Profile Table Theraputic Drug Monitorings Product Introduction, Application and Specification of R-Biopharm AG Table Theraputic Drug Monitorings Revenue (M USD) and Gross Margin of R-Biopharm AG 2018-2023 Table R-Biopharm AG Main Business Table R-Biopharm AG Recent Development Table Sysmex Company Profile Table Theraputic Drug Monitorings Product Introduction, Application and Specification of Sysmex Table Theraputic Drug Monitorings Revenue (M USD) and Gross Margin of Sysmex 2018-2023 Table Sysmex Main Business Table Sysmex Recent Development Table Wieslab Company Profile Table Theraputic Drug Monitorings Product Introduction, Application and Specification of Wieslab Table Theraputic Drug Monitorings Revenue (M USD) and Gross Margin of Wieslab 2018-2023 Table Wieslab Main Business Table Wieslab Recent Development Table Omnica Company Profile Table Theraputic Drug Monitorings Product Introduction, Application and Specification of Omnica Table Theraputic Drug Monitorings Revenue (M USD) and Gross Margin of Omnica 2018-2023 Table Omnica Main Business Table Omnica Recent Development Table ARK Diagnostics Company Profile Table Theraputic Drug Monitorings Product Introduction, Application and Specification of ARK Diagnostics Table Theraputic Drug Monitorings Revenue (M USD) and Gross Margin of ARK Diagnostics 2018-2023 Table ARK Diagnostics Main Business Table ARK Diagnostics Recent Development Table Probe Scientific Company Profile Table Theraputic Drug Monitorings Product Introduction, Application and Specification of Probe Scientific Table Theraputic Drug Monitorings Revenue (M USD) and Gross Margin of Probe Scientific 2018-2023 Table Probe Scientific Main Business Table Probe Scientific Recent Development Table Mergers & Acquisitions Planning Figure Global Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023) Figure Global Theraputic Drug Monitorings Revenue by Regions (2018-2023) Figure Global Theraputic Drug Monitorings Revenue Market Share by Regions in 2022 Figure North America Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023) Figure Europe Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023) Figure Asia-pacific Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023) Figure South America Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023) Figure Middle East & Africa Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023) Figure North America Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023) Table North America Theraputic Drug Monitorings Market Size by Countries (2018-2023) Table North America Theraputic Drug Monitorings Market Share by Countries (2018-2023) Figure North America Theraputic Drug Monitorings Market Share by Countries in 2022 Figure United States Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023) Figure Canada Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023) Figure Mexico Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023) Table North America Theraputic Drug Monitorings Revenue by Vendors (2022) Figure North America Theraputic Drug Monitorings Revenue Market Share by Vendors in 2022 Table North America Theraputic Drug Monitorings Revenue by Type (2018-2023) Table North America Theraputic Drug Monitorings Share by Type (2018-2023) Table North America Theraputic Drug Monitorings Revenue by Application (2018-2023) Table North America Theraputic Drug Monitorings Revenue Share by Application (2018-2023) Figure Europe Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023) Table Europe Theraputic Drug Monitorings Market Size by Countries (2018-2023) Table Europe Theraputic Drug Monitorings Revenue Market Share by Countries (2018-2023) Figure Europe Theraputic Drug Monitorings Revenue Market Share by Countries in 2022 Figure Germany Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023) Figure UK Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023) Figure France Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023) Figure Russia Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023) Figure Italy Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023) Figure Spain Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023) Table Europe Theraputic Drug Monitorings Revenue by Vendors (2022) Figure Europe Theraputic Drug Monitorings Revenue Market Share by Vendors in 2022 Table Europe Theraputic Drug Monitorings Revenue by Type (2018-2023) Table Europe Theraputic Drug Monitorings Revenue Share by Type (2018-2023) Table Europe Theraputic Drug Monitorings Revenue by Application (2018-2023) Table Europe Theraputic Drug Monitorings Revenue Share by Application (2018-2023) Figure Asia-pacific Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023) Table Asia-pacific Theraputic Drug Monitorings Market Size by Countries (2018-2023) Table Asia-pacific Theraputic Drug Monitorings Revenue Market Share by Countries (2018-2023) Figure Asia-pacific Theraputic Drug Monitorings Revenue Market Share by Countries in 2022 Figure China Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023) Figure South Korea Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023) Figure Japan Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023) Figure Australia Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023) Figure India Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023) Figure Southeast Asia Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023) Table Asia-pacific Theraputic Drug Monitorings Revenue by Vendors (2022) Figure Asia-pacific Theraputic Drug Monitorings Revenue Market Share by Vendors in 2022 Table Asia-pacific Theraputic Drug Monitorings Revenue by Type (2018-2023) Table Asia-pacific Theraputic Drug Monitorings Revenue Share by Type (2018-2023) Table Asia-pacific Theraputic Drug Monitorings Revenue by Application (2018-2023) Table Asia-pacific Theraputic Drug Monitorings Revenue Share by Application (2018-2023) Figure South America Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023) Table South America Theraputic Drug Monitorings Revenue Market Size by Countries (2018-2023) Table South America Theraputic Drug Monitorings Revenue Market Share by Countries (2018-2023) Figure South America Theraputic Drug Monitorings Revenue Market Share by Countries in 2020 Figure Brazil Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023) Figure Chile Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023) Table South America Theraputic Drug Monitorings Revenue s by Type (2018-2023) Table South America Theraputic Drug Monitorings Revenue Share by Type (2018-2023) Table South America Theraputic Drug Monitorings Revenue by Application (2018-2023) Table South America Theraputic Drug Monitorings Revenue Share by Application (2018-2023) Figure Middle East and Africa Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023) Table Middle East and Africa Theraputic Drug Monitorings Market Size by Countries (2018-2023) Table Middle East and Africa Theraputic Drug Monitorings Sales Market Share by Countries (2018-2023) Figure Middle East and Africa Theraputic Drug Monitorings Sales Market Share by Countries in 2020 Figure GCC Countries Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023) Figure Turkey Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023) Figure Egypt Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023) Figure South Africa Theraputic Drug Monitorings Revenue and Growth Rate (2018-2023) Table Middle East and Africa Theraputic Drug Monitorings Revenue by Type (2018-2023) Table Middle East and Africa Theraputic Drug Monitorings Revenue Share by Type (2018-2023) Table Middle East and Africa Theraputic Drug Monitorings Revenue by Application (2018-2023) Table Middle East and Africa Theraputic Drug Monitorings Revenue Share by Application (2018-2023) Table Global Theraputic Drug Monitorings Revenue by Type (2018-2023) Table Global Theraputic Drug Monitorings Revenue Market Share by Type (2018-2023) Figure Global Theraputic Drug Monitorings Revenue Market Share by Type in 2020 Figure Global Chemiluminescence Immunoassay (CLIA) Revenue and Growth Rate (2018-2023) Figure Global Fluorescence Immunoassay (FPIA) Revenue and Growth Rate (2018-2023) Figure Global Radioimmunoassay (RIA) Revenue and Growth Rate (2018-2023) Figure Global Colorimetric Immunoassay Revenue and Growth Rate (2018-2023) Figure Global Other Immunoassays Revenue and Growth Rate (2018-2023) Table Global Theraputic Drug Monitorings Revenue by Application (2018-2023) Table Global Theraputic Drug Monitorings Revenue Market Share by Application (2018-2023) Figure Global Theraputic Drug Monitorings Revenue Market Share by Application in 2022 Figure Global Antiepileptic Drugs Revenue Growth Rate (2018-2023) Figure Global Immunosuppressant Revenue Growth Rate (2018-2023) Figure Global Antitumor Drugs Revenue Growth Rate (2018-2023) Figure Global Psychotropic Drugs Revenue Growth Rate (2018-2023) Figure Global Antibiotic Revenue Growth Rate (2018-2023) Figure Global Antifungal Revenue Growth Rate (2018-2023) Figure Global Cardiovascular Drugs Revenue Growth Rate (2018-2023) Figure Global Antiasthmatic Revenue Growth Rate (2018-2023) Figure Global Others Revenue Growth Rate (2018-2023) Figure Global Theraputic Drug Monitorings Revenue and Growth Rate (2023-2028) Table Global Theraputic Drug Monitorings Revenue Forecast by Regions (2023-2028) Table Global Theraputic Drug Monitorings Market Share Forecast by Regions (2023-2028) Figure North America Revenue Theraputic Drug Monitorings Market Forecast (2023-2028) Figure Europe Revenue Theraputic Drug Monitorings Market Forecast (2023-2028) Figure Asia-Pacific Revenue Theraputic Drug Monitorings Market Forecast (2023-2028) Figure South America Revenue Theraputic Drug Monitorings Market Forecast (2023-2028) Figure Middle East & Africa Revenue Theraputic Drug Monitorings Market Forecast (2023-2028) Table Global Theraputic Drug Monitorings Revenue Forecast by Type (2023-2028) Table Global Theraputic Drug Monitorings Market Share Forecast by Type (2023-2028) Table Global Theraputic Drug Monitorings Revenue Forecast by Application (2023-2028) Table Global Theraputic Drug Monitorings Market Share Forecast by Application (2023-2028) Table Market Opportunities in Next Few Years Table Market Risks Analysis Table Market Drivers Figure Porter's Five Forces Analysis Table Macro Analysis of Down Markets Table Key Players in Down Markets Table Key Players of Downstream Markets Figure Author List

Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:

Publisher: Multi Market Insight